Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

被引:290
作者
Miao, H
Wei, BR
Peehl, DM
Li, Q
Alexandrou, T
Schelling, JR
Rhim, JS
Sedor, JR
Burnett, E
Wang, BC
机构
[1] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44109 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44109 USA
[4] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[5] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/35074604
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation(1,2). However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation(3,4) or to transform rodent fibroblasts(5), indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and Vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 50 条
[41]   Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior [J].
Carles-Kinch, K ;
Kilpatrick, KE ;
Stewart, JC ;
Kinch, MS .
CANCER RESEARCH, 2002, 62 (10) :2840-2847
[43]   Anaplastic lymphoma kinase is activated through the Pleiotrophin/Receptor protein-tyrosine phosphatase β/ζ signaling pathway -: An alternative mechanism of receptor tyrosine kinase activation [J].
Perez-Pinera, Pablo ;
Zhang, Wei ;
Chang, Yunchao ;
Antonio Vega, Jose ;
Deuel, Thomas F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (39) :28683-28690
[44]   Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers [J].
Oki, Mariko ;
Yamamoto, Hiroyuki ;
Taniguchi, Hiroaki ;
Adachi, Yasushi ;
Imai, Kohzoh ;
Shinomura, Yasuhisa .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (37) :5650-5656
[45]   Receptor tyrosine kinase EPHA2 is required for epidermal barrier homeostasis [J].
Shi, B. ;
Selph, T. ;
Russell, K. ;
Mahi, T. ;
Khan, E. ;
Martinez, I. ;
Sinchi-Paucar, G. ;
Liu, M. ;
Peng, H. ;
White, B. E. Perez .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) :S133-S133
[46]   Aberrant expression of receptor tyrosine kinase EphA7 in breast cancers [J].
Liu, Zhi ;
Zhang, Qing ;
Li, Xuemin ;
Tao, Zijian .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07) :7352-7358
[47]   Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis [J].
Bogan, Christina ;
Chen, Jin ;
O'Sullivan, M. Gerard ;
Cormier, Robert T. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) :1366-1371
[48]   Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers [J].
Mariko Oki ;
Hiroyuki Yamamoto ;
Hiroaki Taniguchi ;
Yasushi Adachi ;
Kohzoh Imai ;
Yasuhisa Shinomura .
World Journal of Gastroenterology, 2008, (37) :5650-5656
[49]   Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer [J].
Andretta, Elena ;
Carton-Garcia, Fernando ;
Martinez-Barriocanal, Agueda ;
Guimaraes de Marcondes, Priscila ;
Jimenez-Flores, Lizbeth M. ;
Macaya, Irati ;
Bazzocco, Sarah ;
Bilic, Josipa ;
Rodrigues, Paulo ;
Nieto, Rocio ;
Landolfi, Stefania ;
Ramon y Cajal, Santiago ;
Schwartz, Simo, Jr. ;
Brown, Arthur ;
Dopeso, Higinio ;
Arango, Diego .
SCIENTIFIC REPORTS, 2017, 7
[50]   EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics [J].
Ireton, RC ;
Chen, J .
CURRENT CANCER DRUG TARGETS, 2005, 5 (03) :149-157